Alternating Mitomycin C and BCG Instillations versus BCG Alone in Treatment of Carcinoma in Situ of the Urinary Bladder: A Nordic Study

Author： Kaasinen E. Wijkstrom H. Malmstrom P.-U. Hellsten S. Duchek M. Mestad O. Rintala E. The members of the Nordic Urothelial Cancer Group

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.43, Iss.6, 2003-06, pp. : 637-645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nephrotic Syndrome as a Complication of Intravesical BCG Treatment of Transitional Cell Carcinoma of Urinary Bladder

By Singh N. P. Prakash Anupam Kubba Samir Ganguli Anirban Agarwal S. K. Dinda Amit Aggarwal P. N.

Renal Failure, Vol. 29, Iss. 2, 2007-02 ,pp. : 227-229

Informa Healthcare

Access to resources Recommend Favorite

Treatment options for BCG failures

By O’Donnell Michael Boehle Andreas

World Journal of Urology, Vol. 24, Iss. 5, 2006-11 ,pp. : 481-487

Springer Publishing Company

Access to resources Recommend Favorite

Effect of mitomycin-C (MMC) on bacillus Calmette-Guerin (BCG) growth ability in culture

By Mitsogiannis I. Psaroudaki Z. Serafetinides E. Paniara O. Zervas A. Mitropoulos D.

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 122-122

Elsevier

Access to resources Recommend Favorite

Risk factors in carcinoma in situ of the urinary bladder

By Gils-Gielen R.J.M.v. Witjes W.P.J. Caris C.T.M. Debruyne F.M.J. Witjes J.A. Oosterhof G.O.N.

Urology, Vol. 45, Iss. 4, 1995-04 ,pp. : 581-586

Elsevier

Access to resources Recommend Favorite

Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment

By Ick K. Schultz M. Stout P. Fan K.

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite